Immunologic response to xenogeneic gp100 DNA in melanoma patients: comparison of particle-mediated epidermal delivery with intramuscular injection.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Brian A GinsbergJedd D Wolchok

Abstract

Prior studies show that i.m. injection of xenogeneic orthologues of melanosomal antigens (tyrosinase, gp100) induces CD8(+) T-cell responses to the syngeneic protein. To further define the optimal vaccination strategy, we conducted a pilot clinical trial comparing i.m. injection with particle-mediated epidermal delivery (PMED). Human leukocyte antigen (HLA)-A*0201(+) disease-free melanoma patients were randomized to the PMED or i.m. arm, receiving eight vaccinations over 4 months. Patients received 4 microg or 2,000 microg per injection, respectively, of mouse gp100 DNA. Peripheral blood mononuclear cells were collected, cultured with gp100 peptides, and analyzed by tetramer and intracellular cytokine staining for responses to HLA-A*0201-restricted gp100 epitopes [gp100(209-217) (ITDQVPFSV) and gp100(280-288) (YLEPGPVTA)]. Twenty-seven patients with stage IIB-IV melanoma were analyzable for immune response. The only common toxicity was grade 1 injection site reaction in nine patients with no intergroup difference, and one dose-limiting toxicity of acute hypersensitivity occurred in a PMED patient with undiagnosed gold allergy. Four of 27 patients produced gp100 tetramer(+)CD8(+) T cells, all carrying the CCR7(lo)CD45RA(lo) effe...Continue Reading

References

Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·L ChengN S Yang
Sep 17, 1998·The Journal of Clinical Investigation·L W WeberA N Houghton
Nov 6, 1998·The Journal of Experimental Medicine·R DyallJ Nikolić-Zugić
Dec 10, 1999·The Journal of Experimental Medicine·W B BowneA N Houghton
Feb 14, 2002·The Journal of Surgical Research·William G HawkinsAlan N Houghton
Nov 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stacie M GoldbergJedd D Wolchok
Jan 26, 2007·Nature Reviews. Cancer·Ignacio MeleroLieping Chen
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ryan D CassadayMark R Albertini
Aug 30, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jedd D WolchokMiguel A Perales
Sep 18, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Miguel-Angel PeralesJedd D Wolchok
Nov 15, 2008·The Oncologist·Jedd D Wolchok, Yvonne Saenger
Nov 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberEvan Hersh
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jianda YuanJedd D Wolchok
Jan 14, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis H CamachoAntoni Ribas
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sacha GnjaticPadmanee Sharma
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael G LaCelleBernard A Fox
Nov 17, 2009·Clinics in Plastic Surgery·Jonathan Treisman, Nina Garlie
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi

❮ Previous
Next ❯

Citations

Nov 12, 1998·Trends in Biochemical Sciences·C Englert
Jan 5, 2011·Clinical & Developmental Immunology·Georg EschenburgHolger N Lode
Nov 8, 2013·Expert Review of Vaccines·Pier-Luigi LolliniPatrizia Nanni
Jul 16, 2014·Expert Opinion on Biological Therapy·Federica CavalloGennaro Ciliberto
Dec 18, 2013·Urologic Oncology·V T ColluruDouglas G McNeel
Nov 1, 2012·Human Vaccines & Immunotherapeutics·Andrés A HerradaAlvaro Lladser
Jan 28, 2015·Human Vaccines & Immunotherapeutics·Benjamin YangChien-Fu Hung
May 1, 2016·Journal of Biotechnology·Luana R M M ApsMariana O Diniz
May 29, 2016·Pharmacology & Therapeutics·Angeliki Tiptiri-KourpetiKaterina Chlichlia
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hansje-Eva TeulingsRosalie M Luiten
Jun 8, 2017·World Journal of Experimental Medicine·Liliana M E Finocchiaro, Gerardo C Glikin
Apr 9, 2019·The Journal of Gene Medicine·Xiaoyi SunYongzhuo Huang
Jan 1, 2011·Cancers·Luigi Aurisicchio, Gennaro Ciliberto
May 28, 2019·F1000Research·Hoyoung M Maeng, Jay A Berzofsky
Apr 10, 2019·Clinical and Experimental Immunology·J WallisR C Carlisle
Sep 24, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Charles B KemmlerJill E Slansky
Apr 30, 2014·Cancer Immunology Research·Derek Ng TangPadmanee Sharma
Jul 6, 2019·Advanced Drug Delivery Reviews·Naama MargolisGal Markel
May 13, 2021·Cell Transplantation·Chi-Ping HuangChih-Rong Shyr
Jun 25, 2015·Microbiology Spectrum·John S Tregoning, Ekaterina Kinnear
Feb 13, 2017·ACS Biomaterials Science & Engineering·Mingming ZhangChun Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.